×
模态框(Modal)标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框(Modal)标题
在这里添加一些文本
Close
ISSN 1006-298X CN 32-1425/R
Adv Search
Home
About Journal
Editorial Board
Contribution
Journal
Accepted
Current Issue
Archive
Most Download
Most Read
Most Cited
E-mail Alert
RSS
Subscription
Advertising
Contact Us
中文
The cells which produced erythropoietin (EPO) in kidney is called renal EPOproducing cells (REPs). Insufficient production of EPO can cause renal anemia and anemia associated with chronic disease disorders. REPs transformed into scarforming myofibroblasts, resulting in renal fibrosis, chronic kidney disease (CKD) patients the EPOproducing ability of myofibroblasttransformed REPs (MFREPs) is decreased. Recently studies on REPs made great progress and the research is expected to become the treatment of renal anemia and renal interstitial fibrosis new target.
SHAO Fang,XIE Honglang
Chinese Journal of Nephrology, Dialysis & Transplantation . 2017, (
5
): 471 -475 . DOI: 10.3969/j.issn.1006-298X.2017.05.017